Myriad Genetics, Inc., a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating widespread confusion and misconceptions about ovarian cancer screening among a majority of women.
The Myriad Genetics Cancer Risk survey shows that nearly three out of four women falsely believe annual pap smears include testing for ovarian cancer. According to the Centers for Disease Control and Prevention , the "only gynecologic cancer the Pap test screens for is cervical cancer."
Ovarian cancer is one of the deadliest forms of cancer for women due to the lack of screening techniques available and clinically specific symptoms. Many women believe they only need to visit every 3-5 years if they have a normal pap smear result.
Regardless of risk factors, 71% of the women surveyed believe all women should have genetic testing to determine ovarian cancer risk. Two out of three agree that knowing their risk will allow them to take more appropriate preventative measures and 58% agree knowing their risk will help their doctor more appropriately plan treatment should they get cancer.
Related Stories"Our latest survey results underscore the dire need to break down any confusion about ovarian cancer, including symptoms and screening, to help women better understand their cancer risk and how to take appropriate preventative measures," said Melissa Gonzales, president of women's health, Myriad Genetics. "Listening to your body, having open conversations with your doctor and knowing your family history are essential in this quest.
For more information about Myriad's hereditary cancer test and risk assessment, MyRisk® Hereditary Cancer Test with RiskScore®, please visit: https://myriad.com/genetic-tests/myrisk-hereditary-cancer-risk-test/.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
No link found between patient genetics and response to anti-IL17 therapyA new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient's genetic variants and their response to therapy. This study challenges the idea that genetics might significantly account for the variable responses to anti-IL17 therapy seen in the clinic.
Consulte Mais informação »
Unraveling the network of brain tumor geneticsA new map of the network of genetic changes that drive the development of brain tumors has been revealed by UCL researchers. The genetic map, published in Brain, is comparable to a map of the London Underground—where different genetic features responsible for driving brain tumors are like stations connected by tracks.
Consulte Mais informação »
Telehealth services can help women access and understand medical abortionEven before Roe v. Wade was overturned in 2022, many U.S. women lived far from a clinic where they could get abortion pills. Now, a new study suggests that telemedicine can help fill that gap.
Consulte Mais informação »
Overactive bladder symptoms common with pelvic organ prolapseSeven in 10 women with pelvic organ prolapse (POP) report overactive bladder (OAB) symptoms, according to a study published online July 13 in the International Journal of Women's Health.
Consulte Mais informação »
Priced out of pregnancy: the young women who worry they can't afford childrenA common theme among the women I speak to is a sense that 'it takes a whole village to raise a child' - and that 'village' is no longer there as young adults relocate from their hometowns for work
Consulte Mais informação »
Jorge Vilda sacked by Spain Women: Controversial coach leaves post amid RFEF president Luis Rubiales falloutSpain won Womens World Cup final against England; 15 Spain players previously signed a letter calling for Jorge Vildas removal, while he was seen applauding Luis Rubiales during the Spanish FA presidents controversial speech; Montse Tome named as Vildas immediate successor
Consulte Mais informação »